Your session is about to expire
← Back to Search
Behavioural Intervention
Telehealth Cognitive Training for Pediatric Cancer
N/A
Recruiting
Led By Kaitlin McCloskey
Research Sponsored by University of Michigan Rogel Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks from trial entry
Awards & highlights
Study Summary
This trial will explore a new telehealth training program to help kids with cancer and their caregivers. 10 kids and their caregivers will be enrolled at the University of Michigan.
Who is the study for?
This trial is for children aged 8-18 who have completed cancer treatment at least 6 months ago, show attention or executive functioning deficits, and can speak English. It's not for those with developmental, behavioral, mood disorders, traumatic brain injury or seizures, or a history of pediatric brain tumor.Check my eligibility
What is being tested?
The study tests a telehealth cognitive training program designed to help kids who've had cancer improve their attention and problem-solving skills. It involves the child and caregiver in a single group without comparison to other treatments.See study design
What are the potential side effects?
Since this is a non-medical intervention focusing on cognitive training via telehealth sessions, there are no direct physical side effects like you'd expect from medication; however, participants may experience fatigue or frustration.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 weeks from trial entry
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks from trial entry
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Determining satisfaction and perceived benefit from study intervention based off of change in results from the BRIEF-2 questionnaire from baseline to 6 weeks post trial entry
Determining satisfaction and perceived benefit from study intervention based off of change in results from the Conners 3 questionnaire from baseline to 6 weeks post trial entry
Determining satisfaction and perceived benefit from study intervention based off of change in results from the PKEQ questionnaire from baseline to 6 weeks post trial entry
+2 moreOther outcome measures
Clinical outcomes based off of response to the BRIEF-2 study questionnaire
Clinical outcomes based off of response to the Conners 3 study questionnaire
Clinical outcomes based off of response to the PKEQ study questionnaire
+3 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention
The intervention will include 5 weekly sessions (60-90 minutes each) of cognitive compensatory training (CCT) delivered virtually by a pediatric neuropsychologist.
Find a Location
Who is running the clinical trial?
University of Michigan Rogel Cancer CenterLead Sponsor
294 Previous Clinical Trials
24,251 Total Patients Enrolled
Kaitlin McCloskeyPrincipal InvestigatorUniversity of Michigan Rogel Cancer Center
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I was treated for a brain tumor as a child.I am between 8 and 18 years old.I have a developmental, behavioral, or mood disorder that could affect my participation.I finished my last treatment over 6 months ago.I have had a traumatic brain injury or seizures in the past.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger